{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:20:25Z","timestamp":1793211625276,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA28050"],"award-info":[{"award-number":["AA28050"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA27486"],"award-info":[{"award-number":["AA27486"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The opioid epidemic represents a national crisis. Oxycodone is one of the most prescribed opioid medications in the United States, whereas buprenorphine is currently the most prescribed medication for opioid use disorder (OUD) pharmacotherapy. Given the extensive use of prescription opioids and the global opioid epidemic, it is essential to understand how opioids modulate brain cell type function at the single-cell level. We performed single nucleus RNA-seq (snRNA-seq) using iPSC-derived forebrain organoids from three male OUD subjects in response to oxycodone, buprenorphine, or vehicle for seven days. We utilized the snRNA-seq data to identify differentially expressed genes following drug treatment using the Seurat integrative analysis pipeline. We utilized iPSC-derived forebrain organoids and single-cell sequencing technology as an unbiased tool to study cell-type-specific and drug-specific transcriptional responses. After quality control filtering, we analyzed 25787 cells and identified sixteen clusters using unsupervised clustering analysis. Our results reveal distinct transcriptional responses to oxycodone and buprenorphine by iPSC-derived brain organoids from patients with OUD. Specifically, buprenorphine displayed a significant influence on transcription regulation in glial cells. However, oxycodone induced type I interferon signaling in many cell types, including neural cells in brain organoids. Finally, we demonstrate that oxycodone, but not buprenorphine activated STAT1 and induced the type I interferon signaling in patients with OUD. These data suggest that elevation of STAT1 expression associated with OUD might play a role in transcriptional regulation in response to oxycodone. In summary, our results provide novel mechanistic insight into drug action at single-cell resolution.<\/jats:p>","DOI":"10.1038\/s41380-022-01837-8","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T03:02:49Z","timestamp":1666839769000},"page":"1636-1646","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Single cell transcriptomics reveals distinct transcriptional responses to oxycodone and buprenorphine by iPSC-derived brain organoids from patients with opioid use disorder"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3757-3924","authenticated-orcid":false,"given":"Ming-Fen","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4322-5923","authenticated-orcid":false,"given":"Brandon J.","family":"Coombes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9350-4440","authenticated-orcid":false,"given":"Joanna","family":"Biernacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7863-3017","authenticated-orcid":false,"given":"Michelle","family":"Skime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7363-8086","authenticated-orcid":false,"given":"Tyler S.","family":"Oesterle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9552-6130","authenticated-orcid":false,"given":"Victor M.","family":"Karpyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Gliske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quyen","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Skillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin D.","family":"Seppala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5957-5472","authenticated-orcid":false,"given":"Hu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4911-7985","authenticated-orcid":false,"given":"Richard M.","family":"Weinshilboum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,27]]},"reference":[{"key":"1837_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-019-0137-5","volume":"6","author":"J Strang","year":"2020","unstructured":"Strang J, Volkow ND, Degenhardt L, Hickman M, Johnson K, Koob GF, et al. Opioid use disorder. Nat Rev Dis Prim. 2020;6:3.","journal-title":"Nat Rev Dis Prim"},{"key":"1837_CR2","unstructured":"McGranahan D, Parker T. The opioid epidemic: a geography in two phases. Economic Research Service US Departnebt of Agriculture 2021: Economic Research Report No. (ERR-287) 248 pp."},{"key":"1837_CR3","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/j.mayocp.2019.03.029","volume":"94","author":"TS Oesterle","year":"2019","unstructured":"Oesterle TS, Thusius NJ, Rummans TA, Gold MS. Medication-assisted treatment for opioid-use disorder. Mayo Clin Proc. 2019;94:2072\u201386.","journal-title":"Mayo Clin Proc"},{"key":"1837_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1176\/appi.prcp.20180006","volume":"1","author":"M Sofuoglu","year":"2019","unstructured":"Sofuoglu M, DeVito EE, Carroll KM. Pharmacological and behavioral treatment of opioid use disorder. Psychiatr Res Clin Pract. 2019;1:4\u201315.","journal-title":"Psychiatr Res Clin Pract"},{"key":"1837_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/MLR.0000000000000727","volume":"55","author":"B Saloner","year":"2017","unstructured":"Saloner B, Daubresse M, Caleb, Alexander G. Patterns of buprenorphine-naloxone treatment for opioid use disorder in a multistate population. Med Care. 2017;55:669\u201376.","journal-title":"Med Care"},{"key":"1837_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1176\/appi.ajp.2018.17070732","volume":"176","author":"MA Sullivan","year":"2019","unstructured":"Sullivan MA, Bisaga A, Pavlicova M, Carpenter KM, Choi CJ, Mishlen K, et al. A randomized trial comparing extended-release injectable suspension and oral naltrexone, both combined with behavioral therapy, for the treatment of opioid use disorder. Am J Psychiatry. 2019;176:129\u201337.","journal-title":"Am J Psychiatry"},{"key":"1837_CR7","doi-asserted-by":"publisher","first-page":"1329459","DOI":"10.1155\/2016\/1329459","volume":"2016","author":"Y Kim","year":"2016","unstructured":"Kim Y, Rim YA, Yi H, Park N, Park SH, Ju JH. The generation of human induced pluripotent stem cells from blood cells: an efficient protocol using serial plating of reprogrammed cells by centrifugation. Stem cells Int. 2016;2016:1329459.","journal-title":"Stem cells Int"},{"key":"1837_CR8","doi-asserted-by":"crossref","unstructured":"Kim J, Koo B-K, Knoblich JA. Human organoids: model systems for human biology and medicine. Nature Reviews Molecular Cell Biology 2020;21:571\u2013584.","DOI":"10.1038\/s41580-020-0259-3"},{"key":"1837_CR9","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.cell.2016.04.032","volume":"165","author":"X Qian","year":"2016","unstructured":"Qian X, Nguyen HaN, Song Mingxi M, Hadiono C, Ogden Sarah C, Hammack C, et al. Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure. Cell 2016;165:1238\u201354.","journal-title":"Cell"},{"key":"1837_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16159-y","volume":"11","author":"TT Karagiannis","year":"2020","unstructured":"Karagiannis TT, Cleary JP, Gok B, Henderson AJ, Martin NG, Yajima M, et al. Single cell transcriptomics reveals opioid usage evokes widespread suppression of antiviral gene program. Nat Commun. 2020;11:2611.","journal-title":"Nat Commun"},{"key":"1837_CR11","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41593-020-0621-y","volume":"23","author":"C Nagy","year":"2020","unstructured":"Nagy C, Maitra M, Tanti A, Suderman M, Th\u00e9roux J-F, Davoli MA, et al. Single-nucleus transcriptomics of the prefrontal cortex in major depressive disorder implicates oligodendrocyte precursor cells and excitatory neurons. Nat Neurosci. 2020;23:771\u201381.","journal-title":"Nat Neurosci"},{"key":"1837_CR12","doi-asserted-by":"publisher","first-page":"e2027481","DOI":"10.1001\/jamanetworkopen.2020.27481","volume":"3","author":"JF Scherrer","year":"2020","unstructured":"Scherrer JF, Tucker J, Salas J, Zhang Z, Grucza R. Comparison of opioids prescribed for patients at risk for opioid misuse before and after publication of the centers for disease control and prevention\u2019s opioid prescribing guidelines. JAMA Netw Open. 2020;3:e2027481.","journal-title":"JAMA Netw Open"},{"key":"1837_CR13","doi-asserted-by":"crossref","unstructured":"Ling W, Nadipelli VR, Aldridge AP, Ronquest NA, Solem CT, Chilcoat H et al. Recovery from opioid use disorder (OUD) after monthly long-acting buprenorphine treatment: 12-month longitudinal outcomes from RECOVER, an observational study. J of Addiction Med. 2020;14:e233\u2013e240.","DOI":"10.1097\/ADM.0000000000000647"},{"key":"1837_CR14","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/s41380-019-0377-5","volume":"24","author":"KC Vadodaria","year":"2019","unstructured":"Vadodaria KC, Ji Y, Skime M, Paquola AC, Nelson T, Hall-Flavin D, et al. Altered serotonergic circuitry in SSRI-resistant major depressive disorder patient-derived neurons. Mol Psychiatry. 2019;24:808\u201318.","journal-title":"Mol Psychiatry"},{"key":"1837_CR15","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/s41380-019-0363-y","volume":"24","author":"KC Vadodaria","year":"2019","unstructured":"Vadodaria KC, Ji Y, Skime M, Paquola A, Nelson T, Hall-Flavin D, et al. Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons. Mol Psychiatry. 2019;24:795\u2013807.","journal-title":"Mol Psychiatry"},{"key":"1837_CR16","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/nprot.2017.152","volume":"13","author":"X Qian","year":"2018","unstructured":"Qian X, Jacob F, Song MM, Nguyen HN, Song H, Ming G-l. Generation of human brain region\u2013specific organoids using a miniaturized spinning bioreactor. Nat Protoc. 2018;13:565.","journal-title":"Nat Protoc"},{"key":"1837_CR17","first-page":"16","volume":"173","author":"M-F Ho","year":"2022","unstructured":"Ho M-F, Zhang C, Wei L, Zhang L, Moon I, Geske JR, et al. Genetic variants associated with acamprosate treatment response in alcohol use disorder patients: A multiple omics study. Br J Pharmacol. 2022;173:16.","journal-title":"Br J Pharmacol"},{"key":"1837_CR18","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/nature13716","volume":"515","author":"Z Wen","year":"2014","unstructured":"Wen Z, Nguyen HN, Guo Z, Lalli MA, Wang X, Su Y, et al. Synaptic dysregulation in a human iPS cell model of mental disorders. Nature 2014;515:414\u20138.","journal-title":"Nature"},{"key":"1837_CR19","first-page":"S786","volume":"43","author":"M-F Ho","year":"2019","unstructured":"Ho M-F, Zhang L, Moon I, Skime M, Ho AM-C, Choi D-S, et al. TSPAN5, an alcohol responsive gene that alters serotonin levels in human induced pluripotent stem cells: novel molecular links to alcohol use disorder. Alcohol: Clin Exp Res. 2019;43:S786.","journal-title":"Alcohol: Clin Exp Res"},{"key":"1837_CR20","first-page":"296","volume":"80","author":"KP Leow","year":"1995","unstructured":"Leow KP, Cramond T, Smith MT. Pharmacokinetics and pharmacodynamics of oxycodone when given intravenously and rectally to adult patients with cancer pain. Anesthesia Analgesia. 1995;80:296\u2013302.","journal-title":"Anesthesia Analgesia"},{"key":"1837_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jsat.2017.04.008","volume":"78","author":"C Haasen","year":"2017","unstructured":"Haasen C, Linden M, Tiberg F. Pharmacokinetics and pharmacodynamics of a buprenorphine subcutaneous depot formulation (CAM2038) for once-weekly dosing in patients with opioid use disorder. J Subst Abus Treat. 2017;78:22\u20139.","journal-title":"J Subst Abus Treat"},{"key":"1837_CR22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/ADM.0b013e31806dcc3e","volume":"1","author":"P Compton","year":"2007","unstructured":"Compton P, Ling W, Chiang CN, Moody DE, Huber A, Ling D, et al. Pharmacokinetics of buprenorphine: a comparison of sublingual tablet versus liquid after chronic dosing. J Addiction Med. 2007;1:88\u201395.","journal-title":"J Addiction Med"},{"key":"1837_CR23","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","volume":"33","author":"R Satija","year":"2015","unstructured":"Satija R, Farrell JA, Gennert D, Schier AF, Regev A. Spatial reconstruction of single-cell gene expression data. Nat Biotechnol. 2015;33:495\u2013502.","journal-title":"Nat Biotechnol"},{"key":"1837_CR24","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36:411\u201320.","journal-title":"Nat Biotechnol"},{"key":"1837_CR25","first-page":"1888","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM 3rd, et al. Comprehensive Integration of Single- Cell Data. Cell 2019;177:1888\u20131902.e1821.","journal-title":"Cell Data. Cell"},{"key":"1837_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10220","volume":"7","author":"RJ Kimmerling","year":"2016","unstructured":"Kimmerling RJ, Lee Szeto G, Li JW, Genshaft AS, Kazer SW, Payer KR, et al. A microfluidic platform enabling single-cell RNA-seq of multigenerational lineages. Nat Commun. 2016;7:10220.","journal-title":"Nat Commun"},{"key":"1837_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.neuron.2017.09.026","volume":"96","author":"YE Wu","year":"2017","unstructured":"Wu YE, Pan L, Zuo Y, Li X, Hong W. Detecting activated cell populations using single-cell RNA-Seq. Neuron. 2017;96:313\u201329.e316.","journal-title":"Neuron"},{"key":"1837_CR28","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/nar\/gku1003","volume":"43","author":"D Szklarczyk","year":"2015","unstructured":"Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43:D447\u201352.","journal-title":"Nucleic Acids Res"},{"key":"1837_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nature22330","volume":"545","author":"F Birey","year":"2017","unstructured":"Birey F, Andersen J, Makinson CD, Islam S, Wei W, Huber N, et al. Assembly of functionally integrated human forebrain spheroids. Nature 2017;545:54\u20139.","journal-title":"Nature"},{"key":"1837_CR30","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/s41380-020-0676-x","volume":"26","author":"J Dang","year":"2021","unstructured":"Dang J, Tiwari SK, Agrawal K, Hui H, Qin Y, Rana TM. Glial cell diversity and methamphetamine-induced neuroinflammation in human cerebral organoids. Mol Psychiatry. 2021;26:1194\u2013207.","journal-title":"Mol Psychiatry"},{"key":"1837_CR31","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.biopsych.2021.06.007","volume":"90","author":"ML Seney","year":"2021","unstructured":"Seney ML, Kim S-M, Glausier JR, Hildebrand MA, Xue X, Zong W, et al. Transcriptional alterations in dorsolateral prefrontal cortex and nucleus accumbens implicate neuroinflammation and synaptic remodeling in opioid use disorder. Biol Psychiatry. 2021;90:550\u201362.","journal-title":"Biol Psychiatry"},{"key":"1837_CR32","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/ijnp\/pyab043","volume":"24","author":"A Liu","year":"2021","unstructured":"Liu A, Dai Y, Mendez EF, Hu R, Fries GR, Najera KE, et al. Genome-wide correlation of DNA methylation and gene expression in postmortem brain tissues of opioid use disorder patients. Int J Neuropsychopharmacol. 2021;24:879\u201391.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1837_CR33","doi-asserted-by":"crossref","unstructured":"Blanco C, Volkow ND. Management of opioid use disorder in the USA: present status and future directions. The Lancet 2019;393:1760\u20131772.","DOI":"10.1016\/S0140-6736(18)33078-2"},{"key":"1837_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41397-022-00265-9","volume":"22","author":"GS Lopes","year":"2022","unstructured":"Lopes GS, Lopes JL, Bielinski SJ, Armasu SM, Zhu Y, Cavanaugh DC, et al. Identification of sex-specific genetic associations in response to opioid analgesics in a White, non-Hispanic cohort from Southeast Minnesota. Pharmacogenomics J. 2022;22:117\u201323.","journal-title":"Pharmacogenomics J"},{"key":"1837_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/ije\/dyz123","volume":"49","author":"SJ Bielinski","year":"2020","unstructured":"Bielinski SJ, St Sauver JL, Olson JE, Larson NB, Black JL, Scherer SE, et al. Cohort profile: the right drug, right dose, right time: using genomic data to individualize treatment protocol (RIGHT Protocol). Int J Epidemiol. 2020;49:23\u20134.","journal-title":"Int J Epidemiol"},{"key":"1837_CR36","doi-asserted-by":"crossref","unstructured":"Noble F, Marie N. Management of Opioid Addiction With Opioid Substitution Treatments: Beyond Methadone and Buprenorphine. Frontiers in psychiatry 2019;9:742.","DOI":"10.3389\/fpsyt.2018.00742"},{"key":"1837_CR37","doi-asserted-by":"crossref","unstructured":"Franchi S, Moschetti G, Amodeo G, Sacerdote P. Do All Opioid Drugs Share the Same Immunomodulatory Properties? A Review From Animal and Human Studies. Frontiers in Immunology 2019;10:2914.","DOI":"10.3389\/fimmu.2019.02914"},{"key":"1837_CR38","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1007\/s00213-017-4657-y","volume":"234","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Liang Y, Levran O, Randesi M, Yuferov V, Zhao C, et al. Alterations of expression of inflammation\/immune-related genes in the dorsal and ventral striatum of adult C57BL\/6J mice following chronic oxycodone self-administration: a RNA sequencing study. Psychopharmacol (Berl). 2017;234:2259\u201375.","journal-title":"Psychopharmacol (Berl)"},{"key":"1837_CR39","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1016\/j.celrep.2018.08.080","volume":"24","author":"D Avey","year":"2018","unstructured":"Avey D, Sankararaman S, Yim AKY, Barve R, Milbrandt J, Mitra RD. Single-cell RNA-Seq uncovers a robust transcriptional response to morphine by glia. Cell Rep. 2018;24:3619\u201329.e3614.","journal-title":"Cell Rep"},{"key":"1837_CR40","doi-asserted-by":"publisher","first-page":"eaba4221","DOI":"10.1126\/sciadv.aba4221","volume":"6","author":"KE Savell","year":"2020","unstructured":"Savell KE, Tuscher JJ, Zipperly ME, Duke CG, Phillips RA, Bauman AJ, et al. A dopamine-induced gene expression signature regulates neuronal function and cocaine response. Sci Adv. 2020;6:eaba4221.","journal-title":"Sci Adv"},{"key":"1837_CR41","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/nrn3119","volume":"12","author":"RZ Goldstein","year":"2011","unstructured":"Goldstein RZ, Volkow ND. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci. 2011;12:652\u201369.","journal-title":"Nat Rev Neurosci"},{"key":"1837_CR42","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1152\/physrev.00014.2018","volume":"99","author":"ND Volkow","year":"2019","unstructured":"Volkow ND, Michaelides M, Baler R. The neuroscience of drug reward and addiction. Physiological Rev. 2019;99:2115\u201340.","journal-title":"Physiological Rev"},{"key":"1837_CR43","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci"},{"key":"1837_CR44","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson K-F, Subramanian A, Sihag S, Lehar J, et al. PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267.","journal-title":"Nat Genet"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01837-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01837-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01837-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T06:04:16Z","timestamp":1725343456000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01837-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1837"],"URL":"https:\/\/doi.org\/10.1038\/s41380-022-01837-8","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,27]]},"assertion":[{"value":"2 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RMW is a cofounder of and stockholder in OneOme LLC, a pharmacogenomics decision-support company. All other authors have no conflicts to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}